Roger K. Cady
Corporate Officer/Principal chez ALDER BIOPHARMACEUTICALS, INC.
Profil
Roger K.
Cady is the founder of Primary Care Network, Inc. He is currently the Director of the National Headache Foundation and the Vice President-Neurology at Lundbeck Seattle BioPharmaceuticals, Inc. He was previously the Medical Director at Shealy Institute for Comprehensive Pain.
He received his undergraduate degree from Drake University and his doctorate from Mayo Medical School.
Postes actifs de Roger K. Cady
| Sociétés | Poste | Début |
|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 06/06/2016 |
| National Headache Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Roger K. Cady
| Sociétés | Poste | Fin |
|---|---|---|
Shealy Institute for Comprehensive Pain
 Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Directeur Technique/Scientifique/R&D | - |
Primary Care Network, Inc.
 Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Fondateur | - |
Formation de Roger K. Cady
| Drake University | Undergraduate Degree |
| Mayo Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Primary Care Network, Inc.
Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Health Services |
Shealy Institute for Comprehensive Pain
Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Health Services |
| National Headache Foundation |
